|
|
- 2016
Genomically personalized therapy in head and neck cancerDOI: 10.1186/s41199-016-0004-y Keywords: Cetuximab, PIK3CA Mutation, CCND1 Amplification, PIK3CA Amplification, Tumor Mutation Burden Abstract: Genomically driven dysregulated pathways and potential matched therapies in HNSCC. Combination strategies currently being tested in ongoing clinical trials are also shown. Abbreviations: MAB, monoclonal antibody; TKI, tyrosine kinase inhibito
|
